Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based Colonoscopy

Journal of Clinical Gastroenterology

Volumn 52, Issue 9, 2018, Pages 821-827

  Jen, Hsiao Hsuan ^a   Hsu, Chen Yang ^a   Chen, Sam Li Sheng ^b   Yen, Amy Ming Fang ^b   Chiu, Sherry Yueh Hsia ^d   Fann, Jean Ching Yuan ^e   Lee, Yi Chia ^c   Wu, Ming Shiang ^c   Hsu, Wen Feng ^a,f   Peng, Szu Min ^a   Chen, Hsiu Hsi ^a   Chiu, Han Mo ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e KAINAN UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

colonoscopy; colorectal cancer screening; waiting time

Indexed keywords

AGED; CHEMISTRY; COLONOSCOPY; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; FECES; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PROCEDURES; TAIWAN;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; TAIWAN; WAITING LISTS;

EID: 85054020531     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000955     Document Type: Article

References (19)

1. Chiu HM, Chen LS, Yen MF, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the one million Taiwanese screening program. Cancer. 2015;121:3221-3229.
2. Zorzi M, Fedeli U, Schievano E, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut. 2015;64:784-790.
3. Giorgi Rossi P, Vicentini M, Sacchettini C, et al. Impact of screening program on incidence of colorectal cancer: a cohort study in Italy. Am J Gastroenterol. 2015;110:1359-1366.
4. Libby G, Brewster DH, McClements PL, et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer. 2012;107:255-259.
5. Benson VS, Atkin WS, Green J, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer. 2012;130:2961-2973.
6. Chen LS, Yen MF, Chiu YH, et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol. 2011;12:551-558.
7. Yen MF, Chen LS, Chiu YH, et al. A new insight into fecal hemoglobin concentration-dependent predictor for colorectal neoplasia. Int J Cancer. 2014;135:1203-1212.
8. Chen HH, Chiu YH, Luh DL, et al. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer. 2004;100:1734-1743.
9. Yu D, Hopman WM, Paterson WG. Wait time for endoscopic evaluation at a Canadian tertiary care centre: comparison with Canadian Association of Gastroenterology targets. Can J Gastroenterol. 2008;22:621-626.
10. Denters MJ, Deutekom M, Bossuyt PM, et al. Patient burden of colonoscopy after positive fecal immunochemical testing for colorectal cancer screening. Endoscopy. 2013;45:342-349.
11. Chiang TH, Chuang SL, Chen LS, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cut-off concentration in a nationwide colorectal cancer screening program. Gastroenterology. 2014;147: 1317-1326.
12. Chou CK, Chen LS, Yen MF, et al. Outreach and inreach organized service screening programs for colorectal cancer. PloS One. 2016;11:e0155276.
13. Lee YC, Chen LS, Yen MF, et al. Association between colorectal cancer mortality and gradient fecal hemoglobin concentration in colonoscopy noncompliers. J Natl Cancer Inst. 2017;109:djw269.
14. Price J, Campbell C, Sells J, et al. Impact of UK colorectal cancer screening pilot on hospital diagnostic services. J Public Health (Oxf). 2005;27:246-253.
15. van Hees F, Zauber AG, van Veldhuizen H, et al. The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands. Gut. 2015;64:1985-1997.
16. Chen LS, Liao CS, Chang SH, et al. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen. 2007;14:191-199.
17. Hadlock S, Rabeneck L, Paszat LF, et al. Open-access colonoscopy on Ontario: associated factors and quality. Can J Gastroenterol. 2013;27:341-346.
18. Chen LA, Santos S, Jandorf L, et al. A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol. 2008;6:443-450.
19. Nnoaham KE, Lines C. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme. Gut. 2008;57:1238-1245.